PubMed Health⌕ Search

Biomedical subjects

C L Fessler

Publications and source records attributed to C L Fessler.

10 recordsLinked to original sources
PubMed1993

Survival 15 to 20 years after coronary bypass surgery for angina.

OBJECTIVES: The aim of this study was to determine the 15- to 20-year outcome of coronary bypass surgery in patients with angina. BACKGROUND: Coronary bypass surgery has been performed for > 20 years; we need to know the expected outcome of a very long-term follow-up. METHODS: Using actuarial techniques, we determined the outcome of coronary bypass surgery performed for chronic stable and unstable angina in 7,529 patients from 1969 to 1988. RESULTS: The 5-, 10-, 15- and 20-year survival rates (mean +/- SE) were 88 +/- 1, 73 +/- 1, 53 +/- 1 and 38 +/- 3%, respectively, for the whole group. Compared with patients operated on in 1974 to 1988 (n = 7,026), patients operated on in 1969 to 1973 (n = 503) were younger and had less coronary artery disease but had a higher operative mortality rate and a shorter long-term survival time; 15- and 20-year survival of the 1969 to 1973 cohort was 47 +/- 2% and 33 +/- 3%, respectively. The 1974 to 1988 cohort of patients had a 2.1% operative mortality rate and a 10- and 15-year survival probability of 74 +/- 1% and 55 +/- 2%, respectively. For 2,128 patients with "normal" left ventricular function, the 10- and 15-year survival probability was 82 +/- 1% and 64 +/- 3%, respectively, and for 2,413 patients with "abnormal" left ventricular function, it was 66 +/- 1% and 47 +/- 3%, respectively (p < 0.0001); for men it was 74 +/- 1% and 56 +/- 2%, respectively, and for women, 70 +/- 2% and 52 +/- 5%, respectively, p < 0.05. The actuarial percentages of reoperation and myocardial infarction at 15 years were 33 +/- 2% and 26 +/- 2%, respectively; these values did not differ significantly between men and women. There was a significant (p < 0.001) difference between men and women in angina status; 81% of the men versus 74% of the women had no angina or mild angina at the most recent follow-up study. CONCLUSIONS: Coronary bypass surgery is an effective form of therapy for angina (for 15 to 20 years) in both men and women.

Age Factors↗
PubMed1992

Inadequate internal mammary artery graft as a cause of postoperative ischemia: incidence, diagnosis and management.

Inadequate left internal mammary artery (LIMA) graft to the left anterior descending artery (LAD) was encountered in 10 of 3,076 patients between 1984 and July 1990. The mean number of bypass grafts was 2.9 per patient. All patients with inadequate LIMA grafts were stable preoperatively with normal to moderately reduced left ventricular function. No technical difficulties were encountered during surgery. All patients were weaned off cardiopulmonary bypass with minimal or no inotropic support. Each patient developed myocardial ischemia of the LAD territory and/or circulatory collapse or recurrent ventricular dysrhythmia during the first 24 h postoperatively. Six patients, who were immediately re-operated on and had an additional saphenous graft to the LAD, recovered with no infarction and good functional results. Four patients, who were medically treated, developed myocardial infarction. In cases of refractory circulatory collapse and/or ventricular dysrhythmia, inadequate LIMA flow should be suspected. We recommend urgent re-operation with additional saphenous vein graft to the LAD.

Aged↗
PubMed1992

Risk of recoarctation in neonates and infants after repair with patch aortoplasty, subclavian flap, and the combined resection-flap procedure.

Between September 1980 and August 1988, 47 patients younger than 12 months (27 neonates and 20 infants) underwent repair of aortic coarctation. Three surgical techniques were used: patch aortoplasty (group A: 5 neonates and 3 infants, mean age 4.5 months), subclavian flap (group B: 11 neonates and 8 infants, mean age 3.1 months), and the combined resection-flap procedure (group C: 11 neonates and 9 infants, mean age 2.7 months). There were 8 early deaths (3 in group A, 3 in group B, and 2 in group C) and 2 late deaths (both in group B), all of which occurred in patients with complex coexisting anomalies. Follow-up included 37 patients (5 in group A, 14 in group B, and 18 in group C) and ranged from 28 to 108 months (mean 68.0, 60.8, and 51.7 months, respectively). Residual arm-leg pressure gradients greater than 10 mm Hg were detected in 4 of 5 patients in group A, 11 of 14 patients in group B, and 1 of 18 patients in group C (p less than 0.005). There were no reoperations in any infant operated on after 1 month of age in any group (0% risk). However, 4 patients who underwent repair during their neonatal period, with recurrent gradients greater than 20 mm Hg, have required reoperation: in group A, 1 of 5 patients (20% risk) (1 of 2 neonates or 50% risk); in group B, 3 of 14 patients (21% risk) (3 of 9 neonates or 33% risk); and none in group C (0% risk in infants and neonates) (p less than 0.001). In summary, residual gradients and risk of recoarctation are significantly higher when a patch or a subclavian flap had been used for repair. The combined resection-flap procedure (an end-to-end anastomosis enlarged with a subclavian flap) is more effective in avoiding gradients and preventing recoarctation, especially in neonates.

Anastomosis, Surgical↗
PubMed1991

Aortic valve replacement in patients over 80 years of age: a comparative standard for balloon valvuloplasty.

Elderly patients who develop symptomatic aortic valvular malfunction have a grave prognosis. Until recently they have not been seriously considered for active treatment, such as valvular surgery or balloon valvuloplasty. Between January 1972 and July 1989, 88 patients over the age of 80 years underwent aortic valve replacement and have been prospectively followed for a total of 185 patient-years. The majority were in New York Heart Association functional class III (48%) or IV (48%) preoperatively. Valvular pathology was pure aortic stenosis in 81%, regurgitation alone in 6%, and mixed lesions in 13% of the cases. Before 1982 the majority of patients received mechanical valves, whereas tissue valves have predominated since then (76% of total). Forty-three percent of the patients had concomitant coronary artery bypass grafting. The overall operative mortality was 16%. Emergency surgery, isolated aortic valve replacement, advanced preoperative functional class, and female gender carried a statistically higher operative mortality. The overall actuarial survival (standard error) at 5 years was 64(7)%. Survival was significantly higher at 5 years for concomitant coronary bypass grafting than for isolated aortic valve replacement, 70 (11)% versus 59(8%), and for males compared to females, 73(9)% versus 55(9)%. The 5-year event-free rates for valve-related death and valve re-replacement were 97(2)% and 93(5)%, respectively. These data provide a firm basis for aortic valve replacement as the standard form of treatment in patients over 80.

Actuarial Analysis↗
PubMed1990

Five-year results of coronary bypass grafting for patients older than 70 years: role of internal mammary artery.

Despite numerous references to the superiority of the internal mammary artery (IMA) over the saphenous vein for myocardial revascularization, its role in the elderly is still in question. From January 1984 through December 1988, 1,081 patients older than 70 years (mean age, 74.9 years) underwent bypass grafting, 354 (33%) receiving left IMA grafts based on the surgeon's preference and 727 (67%) receiving vein grafts only. Selection bias resulted in a higher incidence of known risk factors (such as cardiomegaly, arrhythmias, left ventricular failure, wall motion abnormalities, and preoperative combined New York Heart Association/Canadian Cardiovascular Association functional class IV) in patients in whom the IMA was not used. However, unstable angina, acute myocardial infarction, left ventricular dysfunction, and left main disease were not contraindications for using IMA grafts. The operative mortality rate was significantly lower in IMA patients (2.8% versus 7.6%). The actuarial 5-year survival rate (standard error) was higher in patients with IMA grafts, 89% (3%) versus 78% (2%), and postoperative functional class improved to a greater extent in IMA patients (87% of patients were in classes I and II). Arrhythmias and myocardial infarction were significant causes of late death only in patients with vein grafts. When patients are older than 70 years, patient selection factors clearly play an important role in the differential results between patients in whom the IMA is used and patients in whom vein grafts are used. As in younger patients, excellent results can be achieved in the elderly.

Actuarial Analysis↗
PubMed1989

Long-term survival after postinfarction bypass operation: early versus late operation.

A study of 832 patients operated on within 30 days of infarction from 1974 to 1987 has resulted in 2,388 patient-years (maximum, 14 years) of prospectively acquired follow-up. This study excludes 74 patients in whom cardiogenic shock was the indication for operation. Five-year survival (+/- standard error) was 84% +/- 2%, 85% +/- 1%, and 90% +/- 1%, and 10-year survival was 71% +/- 4%, 68% +/- 1%, and 78% +/- 1% for patients with acute infarction, remote infarction, and no previous infarction, respectively. Age and left ventricular end-diastolic pressure significantly affected long-term survival for patients with acute infarction by both univariate and multivariate analysis. For patients aged less than 65 years, the 5-year and 10-year actuarial survival rates were 89% +/- 2% and 80% +/- 4%, compared with 75% +/- 3% and 58% +/- 9%, respectively, for patients aged more than 65 years. The survival percentages were 89% +/- 2% and 75% +/- 6% for patients with left ventricular end-diastolic pressure less than 15 mm Hg compared with 77% +/- 5% and 67% +/- 7% for patients with left ventricular end-diastolic pressure greater than 15 mm Hg. Operative mortality was 7.6% for patients operated on within 24 hours, compared with 4.1% for patients operated on between 2 and 30 days after infarction. Ten-year survival was similar (about 70%) for all timing groups. Based on these long-term results, there appears to be little to gain by delaying coronary artery bypass grafting, when indicated, after infarction occurs.

Adult↗
PubMed1989

Valve replacement in children under 14 years of age: a review of 22 years of experience.

From 1964 to 1986, a total of 18 valve replacement operations were performed in 15 children under 14 years of age, with 13% operative mortality. Eleven children had a mitral valve replacement, with 3 subsequently requiring reoperation. Twelve Starr-Edwards caged ball prostheses, 1 Björk-Shiley and 1 Carpentier-Edwards prosthesis were implanted in the mitral position, with 18% operative mortality. Three children underwent aortic valve replacement, 1 with a Björk-Shiley prosthesis and 2 with a Starr-Edwards. One patient had tricuspid valve replacement utilizing a Starr-Edwards valve. Thirteen patients had one or more cardiac operations prior to valve replacement. Two late deaths occurred 8 and 18 months, respectively, group, 1 from a cardiac arrhythmia and 1 from fulminating prosthetic valve endocarditis. There were no late deaths in other patients. There was one thromboembolic episode in the entire group. At follow-up, 10 patients were classified as New York Heart Association Functional Class I and 1 patient was Class III. Valve replacement in children can be carried out with low mortality and good long-term results using the Starr-Edwards caged ball prosthesis.

Adolescent↗
PubMed1988

Aortic valve replacement with the Starr-Edwards prosthesis: a comparison of the first and second decades of follow-up.

There are few prostheses in current use that allow 20-year follow-up. This report compares the rates of valve-related complications during the first and second decades following aortic valve replacement with the Silastic ball prosthesis. (table; see text) Valve-related complication rates with this prosthesis have been low overall. Performance characteristics of this valve have remained stable through the second decade of follow-up. These results should be used as the standard in the evaluation of long-term results with other more recently introduced mechanical and tissue valves.

Aortic Valve↗
PubMed1988

Tissue and mechanical valves: mutually advantageous interplay.

This report is concerned with the dynamic interplay between glutaraldehyde preserved tissue valves (bioprostheses) and mechanical valves. These two classes of valve replacement devices are not competitive, but provide some nonoverlapping characteristic advantages and disadvantages. By proper selection, it may be possible to tailor the kind of device used for a particular patient, thus improving the overall results of bioprosthetic and mechanical valve replacement. Careful selection of patients according to age and the safety of anticoagulation should achieve a series of patients with mechanical and bioprosthetic valves that would be superior to a series in which all patients received a single device. Thus, these devices should be viewed as complimentary rather than competitive since the value of properly matching a prosthesis to the patient will be reflected in improved overall results with each class of prosthesis.

Age Factors↗